Vis enkel innførsel

dc.contributor.authorKnapstad, Marit
dc.contributor.authorSmith, Robert Frans Otto
dc.date.accessioned2021-06-29T12:32:53Z
dc.date.available2021-06-29T12:32:53Z
dc.date.created2021-02-02T10:46:35Z
dc.date.issued2021
dc.PublishedDepression and Anxiety. 2021, 1-10.
dc.identifier.issn1091-4269
dc.identifier.urihttps://hdl.handle.net/11250/2762365
dc.description.abstractBackground Prompt Mental Health Care (PMHC, Norwegian adaption of Improving Access to Psychological Therapies) has shown effects on symptoms of anxiety and depression compared to treatment as usual (TAU). In this secondary analysis, we examine the effectiveness of PMHC among clients presenting with symptoms of social anxiety disorder (SAD) and/or agoraphobia on core symptoms at 6- and 12-month follow-up. Methods Randomized controlled trial in two PMHC sites (70:30 ratio PMHC:TAU). Of participants, 61.3% (n = 472) scored at caseness for SAD and 47.7% (n = 367) for agoraphobia (40% both). Effects on SAD avoidance and physiological discomfort (SPIN-9), SAD cognitions (ATQ-SA), agoraphobic avoidance (MIA-8), and agoraphobic cognitions (ATQ-AP) were examined in piecewise growth models. Results The PMHC group showed substantially greater symptom reduction than the TAU group for all outcomes: At 6-month follow-up, the between-group effect sizes were d −0.60 (95% CI: −0.94 to −0.26) for SPIN-9, −0.45 (95% CI: −0.70 to −0.20) for ATQ-SA, −0.50 (95% CI: −0.87 to −0.13) for MIA-8, and −0.61 (95% CI: −0.92 to −0.31) for ATQ-AP. All effects were sustained at similar level at a 12-month follow-up. Conclusion PMHC effectively alleviated SAD and agoraphobia symptoms, and individuals struggling with such symptoms constituted a large proportion of clients. Although results should be interpreted with caution due to risk of attrition bias, they lend further support for a scale-up of PMHC and similar initiatives. Individuals struggling with SAD and/or agoraphobia stood out as relatively high burdened, whereas only one of five had sought help the last 12 months, underscoring the need for the PMHC service.en_US
dc.language.isoengen_US
dc.publisherWileyen_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titleSocial anxiety and agoraphobia symptoms effectively treated by Prompt Mental Health Care versus TAU at 6‐ and 12‐month follow‐up: Secondary analysis from a randomized controlled trialen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2020 The Authorsen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1002/da.23132
dc.identifier.cristin1885751
dc.source.journalDepression and Anxietyen_US
dc.source.pagenumber351-360en_US
dc.identifier.citationDepression and Anxiety. 2021, 38(3), 351-360en_US
dc.source.volume38en_US
dc.source.issue3en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal